Cavela lands $6.6M to help brands beat pre-tariff manufacturing costs; plus Function Health raises $298M Series B at $2.5B valuation

When Anthony Sardain began developing Cavela in 2023, an AI startup that helps brands automate supplier sourcing, he did not foresee that new tariffs would drive customers to become increasingly wary of manufacturing products in China.

Function Health, which offers a regular lab testing service to help people track their health, wants to change that by consolidating health data and making it usable for its customers by connecting that data to an AI model. To further that effort, the company recently raised $298 million in a Series B round led by Redpoint Ventures at a valuation of $2.5 billion.

Learn more about your ad choices. Visit podcastchoices.com/adchoices